Table 3 Demographic characteristics of patient with high S/Co ratio for IgG against N protein.
From: Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes
Variables | S/Co ratio > 1.52 | P value, OR*, CI* | |
|---|---|---|---|
Yes (25) Number (%) | No (75) Number (%) | ||
Male | 15 (30.0) | 10 (20.4) | 0.274 |
Age (years) M ± SD | 63.24 ± 16.95 | 62.64 ± 15.67 | 0.876 |
Height (cm) M ± SD | 164.24 ± 21.83 | 166.48 ± 8.71 | 0.620 |
Weight (lb.) M ± SD | 169.94 ± 35.52 | 176.60 ± 45.18 | 0.457 |
Patient delay (days) | 61 (3.85 ± 3.40) | 22 (5.68 ± 4.28) | 0.047 |
Doctor delay (days) | 60 (3.57 ± 2.90) | 21 (5.24 ± 4.47) | 0.122 |
Current smoker | 1 (16.7) | 24 (25.8) | 0.621 |
Current alcohol ingestion | 7 (26.9) | 18 (24.7) | 0.819 |
Current Marijuana ingestion/inhalational | 1 (50.0) | 24 (24.7) | 0.438 |
Nurse home | 4 (30.8) | 20 (24.4) | 0.624 |
Medication intake prior hospital admission | |||
Chemotherapy | 1 (20.0) | 22 (25.3) | 0.791 |
Inhaled steroid | 1 (8.3) | 22 (27.8) | 0.178 |
Ace inhibitors | 1 (6.3) | 22 (28.9) | 0.089 |
Angiotensin receptor blockers | 2 (14.3) | 21 (26.6) | 0.335 |
Statins | 6 (18.2) | 17 (27.9) | 0.300 |
CT or chest Xray findings obtained after hospital admission | |||
Ground glass opacities | 5 (21.7) | 20 (27.0) | 0.613 |
Consolidation | 2 (13.3) | 23 (28.0) | 0.244 |
Bilateral infiltrates | 18 (34.6) | 7 (15.6) | 0.036, 2.87 (1.07–7.72) |
Laboratory findings within 48 h of hospital admission | |||
Leukocytes (103/uL) | 74 (7.93 ± 5.27) | 25 (9.32 ± 5.02) | 0.254 |
Neutrophils (103/uL) | 74 (8.89 ± 13.52) | 25 (7.89 ± 4.58) | 0.718 |
Lymphocytes (103/uL) | 74 (2.42 ± 4.90) | 25 (1.06 ± 0.67) | 0.022 |
Eosinophils (103/uL) | 72 (0.07 ± 0.18) | 23 (0.03 ± 0.08) | 0.318 |
Hematocrit (%) | 74 (35.40 ± 7.63) | 24 (38.98 ± 6.81) | 0.035 |
Platelet count (103/uL) | 74 (219.39 ± 100.75) | 24 (248.25 ± 137.06) | 0.349 |
WBC > 10,000 | 8 (34.8) | 17 (22.4) | 0.234 |
WBC < 4500 | 4 (17.4) | 21 (27.6) | 0.327 |
Interleukin-6 (pg/mL) | 24 (288.25 ± 707.60) | 13 (674.76 ± 1097.43) | 0.201 |
IL6 > 186 | 5 (55.6) | 8 (28.6) | 0.150 |
C-reactive protein (mg/dL) | 66 (10.53 ± 14.12) | 24 (14.88 ± 11.39) | 0.178 |
CRP > 15 | 9 (37.5) | 15 (22.7) | 0.165 |
Erythrocyte sedimentation rate (mm/hr) | 12 (50.67 ± 25.18) | 4 (59.75 ± 40.97) | 0.600 |
Blood urea nitrogen (mg/dL) | 74 (22.90 ± 21.19) | 25 (23.64 ± 27.38) | 0.889 |
Creatinine (mg/dL) | 74 (1.73 ± 2.67) | 25 (1.20 ± 0.96) | 0.333 |
Ferritin (ng/mL) | 64 (1171.09 ± 2343.46) | 23 (1117.13 ± 895.65) | 0.915 |
Procalcitonin (ng/mL) | 58 (1.33 ± 3.51) | 21 (1.68 ± 6.12) | 0.752 |
Lactate (mmol/L) | 61 (1.99 ± 1.71) | 21 (2.51 ± 2.83) | 0.322 |
Troponin (ng/mL) | 43 (0.03 ± 0.06) | 18 (105.72 ± 448.29) | 0.331 |
Creatine kinase (U/L) | 38 (199.71 ± 357.05) | 17 (425.75 ± 504.77) | 0.108 |
Lactate dehydrogenase (U/L) | 61 (398.10 ± 324.86) | 24 (459.38 ± 195.58) | 0.391 |
Fibrinogen (mg/dL) | 7 (520.43 ± 186.21) | 1 (474.00 ± N/A) | 0.823 |
ALT (U/L) | 69 (70.04 ± 204.74) | 23 (69.35 ± 64.73) | 0.987 |
AST (U/L) | 69 (128.81 ± 642.59) | 23 (85.74 ± 86.31) | 0.750 |
Albumin (mg/dL) | 69 (3.67 ± 0.50) | 23 (3.35 ± 0.53) | 0.017 |
Bilirubin (mg/dL) | 68 (0.65 ± 1.42) | 23 (0.63 ± 0.48) | 0.949 |
D-dimer (ug/mL) | 47 (7.81 ± 39.07) | 18 (5.62 ± 7.59) | 0.815 |
